Thelansis

Bacterial vaginosis, often abbreviated as BV, is characterized by the depletion of natural vaginal lactobacilli and the proliferation of various anaerobic microorganisms in the vaginal mucosa. It is the most common urogenital ailment among women, affecting approximately 19-24% of those in their reproductive years. In the United States, 10-26% of pregnant women have experienced BV. While about 30% of BV cases can resolve independently without medical intervention, this condition can be effectively treated with either clindamycin or metronidazole. Both oral and vaginal application of these medications has proven safe, even during pregnancy. Nonetheless, roughly 10 to 15% of women may not see improvement after the initial antibiotic treatment, necessitating further intervention. It's important to note that BV is not considered a sexually transmitted infection (STI), so there is no need to treat partners, and it is not transmissible between partners. A thorough physical examination can...